A lupane-type triterpene LS-PH inhibits neutrophil activation and protects against acute lung injury by blocking FPR1
Yi-hsuan Wang,Yung-Fong Tsai,Tsong-Long Hwang
DOI: https://doi.org/10.1254/jpssuppl.wcp2018.0_po2-5-1
2018-01-01
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Abstract:Neutrophils play significant pathogenic roles in inflammatory and autoimmune diseases, such as acute respiratory distress syndrome, chronic obstructive pulmonary disorder, rheumatoid arthritis, psoriasis, and systemic lupus erythematosus. Formyl peptide receptor 1 (FPR1) mediates bacterial and mitochondrial N-formyl peptides-induced neutrophil activation. Therefore, FPR1 can act as a therapeutic target for treating neutrophilic inflammatory diseases. In this study, we found that 3,4-seco-4(23), 20(29)-lupadiene-3,28-dioic acid (LS-PH), a lupane-type triterpene isolated from the leaves and branches of Lithocarpus synbalanos (Fagaceae), inhibited superoxide anion generation, reactive oxygen species, elastase release, and adhesion in human neutrophils activated by bacterial and mitochondrial N-formyl peptides (fMLF and fMMYALF). In contrast, LS-PH did not have significant inhibitory effects in non-FPR1 agonists-activated human neutrophils. Importantly, LS-PH bound to FPR1 in human neutrophils and FPR1-transfected HEK293 cells. LS-PH produced right shifts of the concentration-response curves of fMLF- and fMMYALF-induced superoxide anion generation and elastase release, suggesting that LS-PH acts as a competitive antagonist of FPR1. Furthermore, LS-PH competitively inhibited the FPR1-mediated intracellular signalings, including Ca2+ mobilization as well as MAPKs and Akt phosphorylation. In addition, LS-PH diminished neutrophil infiltration, myeloperoxidase activity, and pulmonary edema in lipopolysaccharide-induced lung injury in mice. Our results indicate that LS-PH is a novel FPR1 inhibitor and may have potential as an anti-inflammatory agent for treating neutrophilic lung damage.